Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300154
- Awardee
-
Pierce Biotechnology Inc. UEI CCSJMTEVB1V7 Part of Thermo Electron Corporation
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,427
Award facts
- Contract value 100% obligated
- $4,426.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockford, IL 61105, USA
Award details come from SAM.gov/FPDS.
About this award
Pierce Biotechnology Inc., a subsidiary of Thermo Electron Corporation, received a contract award on October 24, 2011, for the procurement of drugs and biologicals. This Blanket Purchase Agreement (BPA) call, awarded by a civilian federal agency under the Office of the Director, carries a ceiling value of $4,426.56 and utilizes firm fixed-price pricing. The contract was awarded without a set-aside designation and is scheduled for ultimate completion on February 29, 2012, with performance taking place in Rockford, Illinois.
As a child entity of Thermo Electron Corporation, Pierce Biotechnology benefits from its parent company's extensive experience as a leading provider of scientific instruments and related services to the federal government. Thermo Electron's portfolio includes analytical devices, laboratory equipment, and biologicals supplied to agencies such as the Department of Health and Human Services, Department of Defense, and the Environmental Protection Agency. This particular BPA call represents a task order under an existing indefinite delivery vehicle, enabling the federal agency to procure necessary biologicals and related products efficiently without issuing a new solicitation.
Quick answers
Who was awarded contract HHSN26300154?
HHSN26300154 was awarded to Pierce Biotechnology Inc. by Office of the Director (National Institutes of Health) on October 24, 2011.
How much is contract HHSN26300154 worth?
The government has obligated $4,427 on HHSN26300154.
Is contract HHSN26300154 an order under another contract?
Yes. HHSN26300154 is a BPA call under HHSN263199800049380B, a blanket purchase agreement.
Was contract HHSN26300154 competed?
The extent of competition for HHSN26300154 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award